Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability ...

Share on Pinterest A new study shows GLP-1 drugs liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers. Carsten Snejbjerg/Bloomberg via Getty Images ...

KANSAS CITY — Familiar ingredients are likely to be selected by formulators developing products designed to appeal to users of GLP-1 agonist medications. These consumers tend to seek nutrient ...

These medications mimic a gut hormone called GLP-1 (glucagon-like peptide-1), known for its remarkable ability to reduce appetite, balance blood sugar and trigger fat burning. But what if your ...

Prescription drug spending in the United States rose by 10.2% to nearly $806 billion last year, thanks in part to the popularity of GLP weight-loss drugs. GLP-1s are now the top drug category by ...

Adults with mental illness achieved significant reductions in weight loss with GLP-1 therapy. GLP-1s were associated with improvements in depressive symptoms and alcohol use disorder in some studies.

Among patients with diabetes, those taking a GLP-1 had better 3-year survival rates after PCI for a heart attack vs. nonusers. GLP-1 use made no difference in in-stent restenosis or ...

GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health ...

Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators ...